ORIEN Cancer Data Network Adds Collaborators
News Jul 13, 2015
"Becoming part of ORIEN adds great opportunities for Rutgers Cancer Institute of New Jersey, enabling discovery based on large-scale, diverse population data as well as patient-specific clinical decision support across a broad, national clinical trial portfolio," Robert DiPaola, director of the Rutgers Cancer Institute of New Jersey, said in a statement.
ORIEN was launched in May 2014 by the Moffitt Cancer Center and Ohio State University Comprehensive Cancer Center to bring together data to drive research collaborations in oncology and personalized medicine. With the new additions, the network now has nine members.
In February, City of Hope, University of Virginia Cancer Center, University of Colorado Cancer Center, and University of New Mexico Cancer Center joined ORIEN.
Patients in a new Northwestern Medicine study were able to comprehend words that were written but not said aloud. They could write the names of things they saw but not verbalize them. This provides an insight into the brain degeneration that defines the rare dementia termed primary progressive aphasia.